Grant: Master's Award: Canada Graduate Scholarships
University of Toronto
$27,000.00
Evaluating the Association Between Acute Psychedelic Effects and Antidepressant Efficacy of Ketamine: Does the ‘Trip’ Matter?
EF 2024-25
Résumé
Ketamine is a drug that has shown rapid antidepressant effects for people suffering from difficult to treat depression. Ketamine is often associated with psychedelic effects;mind-altering experiences that vary widely from person to person. Many doctors, scientists, and patients believe that the insights patients gain from these psychedelic experiences are the key to the treatment's success. However, current research on this question has been inconclusive and based on studies with small numbers of participants.Our goal is to investigate the association between intensity of psychedelic experience and antidepressant effects to determine if psychedelic effects are required for ketamine benefits. Researchers will analyze data from two large, randomized controlled trials, one involving people with bipolar depression and the other with major depressive disorder. These trials compare an acute course of ketamine to an active placebo, where we will measure both antidepressant effects and the intensity of psychedelic experiences and conduct statistical analyses to determine if they are correlated to one another. The study will also explore whether the link between psychedelic effects and depression improvement might be influenced by functional unblinding, a phenomenon that occurs when people correctly guess that they are receiving ketamine due to its noticeable psychedelic effects, potentially increasing their antidepressant response.If the results show that psychedelic experiences are not necessary for ketamine benefits, it can majorly challenge how these psychedelic treatments are understood and applied. This research can pave the way for developing new ketamine-like therapies without the mind-altering effects, making them more accessible and tolerable for patients.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
530048
Name
Di Luch Sara D
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Evaluating the Association Between Acute Psychedelic Effects and Antidepressant Efficacy of Ketamine: Does the ‘Trip’ Matter?
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Antidepressent Efficacy; Bipolar Depression; Dissociative Effects; Functional Unblinding; Ketamine; Neuropsychopharmacology; Pharmacotherapy; Psychedelic Experience; Psychiatric Disorders; Treatment Resistant Depression
Abstract
Ketamine is a drug that has shown rapid antidepressant effects for people suffering from difficult to treat depression. Ketamine is often associated with psychedelic effects;mind-altering experiences that vary widely from person to person. Many doctors, scientists, and patients believe that the insights patients gain from these psychedelic experiences are the key to the treatment's success. However, current research on this question has been inconclusive and based on studies with small numbers of participants.Our goal is to investigate the association between intensity of psychedelic experience and antidepressant effects to determine if psychedelic effects are required for ketamine benefits. Researchers will analyze data from two large, randomized controlled trials, one involving people with bipolar depression and the other with major depressive disorder. These trials compare an acute course of ketamine to an active placebo, where we will measure both antidepressant effects and the intensity of psychedelic experiences and conduct statistical analyses to determine if they are correlated to one another. The study will also explore whether the link between psychedelic effects and depression improvement might be influenced by functional unblinding, a phenomenon that occurs when people correctly guess that they are receiving ketamine due to its noticeable psychedelic effects, potentially increasing their antidepressant response.If the results show that psychedelic experiences are not necessary for ketamine benefits, it can majorly challenge how these psychedelic treatments are understood and applied. This research can pave the way for developing new ketamine-like therapies without the mind-altering effects, making them more accessible and tolerable for patients.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Di Luch, Sara D
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~